Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Network pharmacology: the next paradigm in drug discovery.

Nature chemical biology

Systems Biology, Structure-Activity Relationship, trends, methods, Pharmacology, Humans, Genomics, Drug Design, Drug Delivery Systems, toxicity, therapeutic use, chemistry, Antineoplastic Agents, Animals

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      The dominant paradigm in drug discovery is the concept of designing maximally selective ligands to act on individual drug targets. However, many effective drugs act via modulation of multiple proteins rather than single targets. Advances in systems biology are revealing a phenotypic robustness and a network structure that strongly suggests that exquisitely selective compounds, compared with multitarget drugs, may exhibit lower than desired clinical efficacy. This new appreciation of the role of polypharmacology has significant implications for tackling the two major sources of attrition in drug development--efficacy and toxicity. Integrating network biology and polypharmacology holds the promise of expanding the current opportunity space for druggable targets. However, the rational design of polypharmacology faces considerable challenges in the need for new methods to validate target combinations and optimize multiple structure-activity relationships while maintaining drug-like properties. Advances in these areas are creating the foundation of the next paradigm in drug discovery: network pharmacology.

      Related collections

      Author and article information

      Journal
      10.1038/nchembio.118
      18936753

      Comments

      Comment on this article